Publication:
Ultrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefits

dc.contributor.authorSurachate Siripongsakunen_US
dc.contributor.authorSirachat Vidhyarkornen_US
dc.contributor.authorSirivipa Charuswattanakulen_US
dc.contributor.authorPoemlarp Mekraksakiten_US
dc.contributor.authorPrakongboon Sungkasubunen_US
dc.contributor.authorNuphat Yodkhunnathumen_US
dc.contributor.authorSutthirak Tangruangkiaten_US
dc.contributor.authorNapat Ritlumlerten_US
dc.contributor.authorThaniya Sricharunraten_US
dc.contributor.authorSirima Jaroenpatarapesajen_US
dc.contributor.authorKamonwan Soonklangen_US
dc.contributor.authorAnond Kulthanmanusornen_US
dc.contributor.authorChirayu U. Auewarakulen_US
dc.contributor.authorChulabhorn Mahidolen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.contributor.otherChulabhorn Royal Academyen_US
dc.contributor.otherBan Luang Hospitalen_US
dc.contributor.otherChulabhorn Hospitalen_US
dc.date.accessioned2019-08-28T06:03:04Z
dc.date.available2019-08-28T06:03:04Z
dc.date.issued2018-07-01en_US
dc.description.abstract© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd Background and Aim: Cholangiocarcinoma (CCA) is an aggressive malignancy with rapid progression and poor prognosis. Abdominal ultrasound surveillance may detect early-stage malignancy and improve surgical outcome. However, little data exist on the benefits of abdominal ultrasound surveillance in populations at high risk for CCA development in an endemic area. This study compared survival outcomes of CCA patients recruited through abdominal ultrasound surveillance program and those presented to the hospital independent of surveillance. Methods: The surveillance population-based cohort was 4225 villagers in Northern Thailand, aged 30–60 years, who consented to a 5-year abdominal ultrasound surveillance program, which included interval ultrasound examinations every 6 months. The non-surveillance cohort was hospital-based CCA patients diagnosed during April 2007 to November 2015. Numbers of operable tumors, percentages of R0 resection, and survival analyses were compared between the two cohorts. Results: There were 48 and 192 CCA patients in the surveillance and the non-surveillance cohorts, respectively. Of these, 37/48 (77.1%) and 22/192 (11.5%) were in an operable stage and R0 resections performed in 36/48 (97.3%) and 14/192 (63.6%), respectively. The median survival in each group was 31.8 and 6.7 months, respectively (with correction of lead time bias) (P < 0.0001). By multivariate analysis, abdominal ultrasound surveillance (hazard ratio [HR] = 0.41; P = 0.012), operable stage (HR = 0.11; P < 0.001), and serum albumin ≥ 3.5 g/dL (HR = 0.42; P < 0.001) were significantly associated with decreased mortality, whereas size of CCA (HR = 1.11; P < 0.001), serum alanine aminotransferase > 40 IU/L (HR = 1.71; P = 0.017), and tumor recurrence (HR = 4.86; P = 0.017) were associated with increased mortality. Conclusion: Abdominal ultrasound surveillance provided survival benefits and should be considered in areas highly endemic for CCA to reduce mortality.en_US
dc.identifier.citationJournal of Gastroenterology and Hepatology (Australia). Vol.33, No.7 (2018), 1383-1388en_US
dc.identifier.doi10.1111/jgh.14074en_US
dc.identifier.issn14401746en_US
dc.identifier.issn08159319en_US
dc.identifier.other2-s2.0-85048249768en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/46569
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048249768&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleUltrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefitsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85048249768&origin=inwarden_US

Files

Collections